about
Helus Pharma Inc is a clinical-stage pharmaceutical company developing proprietary novel serotonergic agonists (NSAs), which are synthetic molecules designed to activate serotonin pathways associated with neuroplasticity. These compounds are being in...
Read More
6.62
-0.15
(-2.22%)
455.0K
XNAS Volume
XNAS 30 Jan, 2026 4:15 PM (EST)
Not Eligible
Not Eligible
No Score Avaliable
Helus Pharma Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..